In collaboration with: Istituto Superiore di Sanità
Over the past few years immunotherapy of tumours has significantly evolved, contributing to increased know-how and experience relating to how to strengthen immunological responses against cancers. The goal of the meeting was to discuss the state of the art and perspectives in the field by analysing the reports of clinical studies conducted in research and clinical centres of excellence in this area of great interest for big pharma. More than 150 people attended the event.